Current Drug Targets
Title:Editorial (Thematic Issue: New Drug Targets for Treatment of Recurrent/Metastatic Prostate Cancer)
Volume: 17 Issue: 3
Author(s): Claudio Festuccia, Paola Negri-Cesi and Giovanni Luca Gravina
Affiliation:
Export Options
About this article
Cite this article as:
Festuccia Claudio, Negri-Cesi Paola and Gravina Luca Giovanni, Editorial (Thematic Issue: New Drug Targets for Treatment of Recurrent/Metastatic Prostate Cancer), Current Drug Targets 2016; 17 (3) . https://dx.doi.org/10.2174/138945011703160125124500
DOI https://dx.doi.org/10.2174/138945011703160125124500 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Current and Future Clinical Strategies in Colon Cancer Prevention and the Emerging Role of Chemoprevention
Current Pharmaceutical Design Melanocortin - 4 Receptor Agonists for the Treatment of Obesity
Current Topics in Medicinal Chemistry Mutant Epidermal Growth Factor Receptors as Targets for Cancer Therapy
Current Cancer Drug Targets Nutlins and Ionizing Radiation in Cancer Therapy
Current Pharmaceutical Design Stem Cell Patents: An Innovative Approach to Anti-Cancer Drug Discovery
Recent Patents on Anti-Cancer Drug Discovery Cytostatic Effect of the Nucleoside Analogue 2-Chloroadenosine on Human Prostate Cancer Cell Line
Current Pharmaceutical Analysis Telomerase Inhibitors: Potential Anticancer Agents
Mini-Reviews in Organic Chemistry Editorial [Hot Topic: Bringing Drugs Into the Injured Brain and Keeping Them There (Executive Guest Editors: Dirk M. Hermann and Pauline Patak)]
Current Pharmaceutical Design The Potential Role of Claudins in Regulation of Metastasis and Development of Drug Resistance in Breast Cancer
Clinical Cancer Drugs Glucuronides in Anti-Cancer Therapy
Current Medicinal Chemistry - Anti-Cancer Agents The Impact of Comorbid Diabetes Type 2 on Quality of Life in Cancer Patients Undergoing Chemotherapy
Endocrine, Metabolic & Immune Disorders - Drug Targets LRIGs: A Prognostically Significant Family with Emerging Therapeutic Competence against Cancers
Current Cancer Drug Targets Targeting Different Signaling Pathways with Antisense Oligonucleotides Combination for Cancer Therapy
Current Pharmaceutical Design Rab GTPases, Membrane Trafficking and Diseases
Current Drug Targets Angiogenesis and Angiogenesis Inhibitors: a New Potential Anticancer Therapeutic Strategy
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Mechanisms of ERK1/2 Regulation by Seven-Transmembrane-Domain Receptors
Current Pharmaceutical Design Meet Our Editorial Board Member
Current Signal Transduction Therapy AGE-RAGE System and Carcinogenesis
Current Pharmaceutical Design Taxane Induced Cystoid Macular Edema: Case Report and Integrated Pathogenic Theory
Current Drug Safety Titanocene Y - Transport and Targeting of an Anticancer Drug Candidate
Letters in Drug Design & Discovery